ATE435853T1 - Prostaglandinanaloga - Google Patents
ProstaglandinanalogaInfo
- Publication number
- ATE435853T1 ATE435853T1 AT05756187T AT05756187T ATE435853T1 AT E435853 T1 ATE435853 T1 AT E435853T1 AT 05756187 T AT05756187 T AT 05756187T AT 05756187 T AT05756187 T AT 05756187T AT E435853 T1 ATE435853 T1 AT E435853T1
- Authority
- AT
- Austria
- Prior art keywords
- analoga
- prostaglandin
- compounds
- prodrug
- useful
- Prior art date
Links
- 150000003180 prostaglandins Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
- C07D223/10—Oxygen atoms attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58514204P | 2004-07-02 | 2004-07-02 | |
| US60018004P | 2004-08-09 | 2004-08-09 | |
| PCT/US2005/019408 WO2006014206A1 (en) | 2004-07-02 | 2005-05-31 | Prostaglandin analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE435853T1 true ATE435853T1 (de) | 2009-07-15 |
Family
ID=34971749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05756187T ATE435853T1 (de) | 2004-07-02 | 2005-05-31 | Prostaglandinanaloga |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7326698B2 (de) |
| EP (1) | EP1765785B1 (de) |
| AT (1) | ATE435853T1 (de) |
| AU (1) | AU2005270229B2 (de) |
| CA (1) | CA2571782C (de) |
| DE (1) | DE602005015323D1 (de) |
| DK (1) | DK1765785T3 (de) |
| ES (1) | ES2327251T3 (de) |
| WO (1) | WO2006014206A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7531533B2 (en) | 2005-01-27 | 2009-05-12 | Asahi Kasei Pharma Corporation | 6-Membered heterocyclic compound and use thereof |
| AU2008246579A1 (en) | 2007-05-08 | 2008-11-13 | National University Corporation, Hamamatsu University School Of Medicine | Cytotoxic T cell activator comprising EP4 agonist |
| IT1402047B1 (it) * | 2010-10-19 | 2013-08-28 | Cross Pharma Sa | Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2452536A1 (de) * | 1974-11-06 | 1976-05-13 | Hoechst Ag | Pyrrolidone und verfahren zu ihrer herstellung |
| US4166452A (en) * | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| ZA802765B (en) * | 1979-05-23 | 1981-05-27 | Beecham Group Ltd | Novel compounds |
| US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| CA2021316C (en) * | 1989-07-27 | 2000-10-24 | Ming Fai Chan | Intraocular pressure reducing 11-acyl prostaglandins |
| US4994274A (en) * | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
| US5034413A (en) * | 1989-07-27 | 1991-07-23 | Allergan, Inc. | Intraocular pressure reducing 9,11-diacyl prostaglandins |
| US5028624A (en) * | 1989-07-27 | 1991-07-02 | Allergan, Inc. | Intraocular pressure reducing 9,15-diacyl prostaglandins |
| JPH0586034A (ja) | 1991-09-27 | 1993-04-06 | Nippon Oil & Fats Co Ltd | ヒドロキシル基含有ラクタム誘導体及びその製造方法 |
| EA005817B1 (ru) * | 2000-08-01 | 2005-06-30 | Фармасиа Корпорейшн | Производные гексагидро-7-1h-азепин-2-илгексановой (или гексеновой) кислоты в качестве ингибиторов индуцибельной синтазы оксида азота |
| US6747037B1 (en) * | 2003-06-06 | 2004-06-08 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
-
2005
- 2005-05-31 DK DK05756187T patent/DK1765785T3/da active
- 2005-05-31 AU AU2005270229A patent/AU2005270229B2/en not_active Ceased
- 2005-05-31 DE DE602005015323T patent/DE602005015323D1/de active Active
- 2005-05-31 ES ES05756187T patent/ES2327251T3/es active Active
- 2005-05-31 EP EP05756187A patent/EP1765785B1/de not_active Not-in-force
- 2005-05-31 AT AT05756187T patent/ATE435853T1/de not_active IP Right Cessation
- 2005-05-31 CA CA2571782A patent/CA2571782C/en not_active Expired - Fee Related
- 2005-05-31 WO PCT/US2005/019408 patent/WO2006014206A1/en not_active Application Discontinuation
- 2005-05-31 US US10/549,959 patent/US7326698B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006014206A1 (en) | 2006-02-09 |
| US20070054893A1 (en) | 2007-03-08 |
| DE602005015323D1 (de) | 2009-08-20 |
| AU2005270229B2 (en) | 2012-04-12 |
| CA2571782C (en) | 2012-07-03 |
| ES2327251T3 (es) | 2009-10-27 |
| AU2005270229A1 (en) | 2006-02-09 |
| DK1765785T3 (da) | 2009-11-02 |
| EP1765785B1 (de) | 2009-07-08 |
| EP1765785A1 (de) | 2007-03-28 |
| US7326698B2 (en) | 2008-02-05 |
| CA2571782A1 (en) | 2006-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE440603T1 (de) | 8-hydroxychinolinderivate | |
| NO20060408L (no) | Fremgangsmate for a modulere kalsium ione-frigjorings- aktivert kalsium ionekanaler | |
| DK1814848T3 (da) | 2,3,4-substitueret-cyclopentanoner som terapeutiske midler | |
| HRP20090281T1 (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
| CY1110835T1 (el) | Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c | |
| WO2005110410A3 (en) | Kinase inhibitors as therapeutic agents | |
| WO2006098918A3 (en) | Substituted gamma lactams as therapeutic agents | |
| NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
| EA200800760A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
| EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| WO2007087395A3 (en) | UNSATURATED mTOR INHIBITORS | |
| EA200801199A1 (ru) | Ингибиторы киназы | |
| WO2007084728A3 (en) | 2-imino-benzimidazoles | |
| EA200800302A1 (ru) | Применение производных и аналогов тиазола при лечении рака | |
| ATE384058T1 (de) | Thiazolderivate | |
| WO2007024843A3 (en) | Pyrimidinyl-pyrazole inhibitors of aurora kinases | |
| MX2009003081A (es) | Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas. | |
| WO2006081431A3 (en) | Compounds for treating inflammatory and demyelinating diseases | |
| ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| WO2008008660A3 (en) | Cyclopentane derivatives as antiglaucoma agents | |
| DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
| TNSN08369A1 (en) | Benzimidazole derivatives | |
| ATE435853T1 (de) | Prostaglandinanaloga | |
| TW200635592A (en) | Pyridyl-substituted spiro-hydantoin compounds and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |